SY Park, et al 10. Ramsey MA, Bradley SF, Kauffman CA, Morton TM. Iden- tification of chromosomal location of mupA gene, encoding low-level mupirocin resistance in staphylococcal isolates. Antimicrob Agents Chemother 1996;40:2820-2823. 11. Murchan S, Kaufmann ME, Deplano A, de Ryck R, Struelens M, Zinn CE, et al. Harmonization of pulsed-field gel electro- phoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains. J Clin Microbiol 2003;41:1574-1585. 12. Heyndrickx M, Vandemeulebroecke K, Scheldeman P, Kers- ters K, de Vos P, Logan NA, et al. A polyphasic reassessment of the genus Paenibacillus, reclassification of Bacillus lautus (Nakamura 1984) as Paenibacillus lautus comb. nov. and of Bacillus peoriae (Montefusco et al. 1993) as Paenibacillus peoriae comb. nov., and emended descriptions of P. lautus and of P. peoriae. Int J Syst Bacteriol 1996;46:988-1003. 13. Sokal RR, Michener CD. A statistical method for evaluating systematic relationships. University of Kansas Scientific Bulletin 1958;28:1409-1438. 14. Rahman M, Noble WC, Cookson B, Baird D, Coia J. Mupiro- cinresistant staphylococcus aureus. Lancet 1987;330:387-388. 15. Conly JM, Vas S. Increasing mupirocin resistance of Staphy- lococcus aureus in CAPD--should it continue to be used as prophylaxis? Perit Dial Int 2002;22:649-652. 16. Pérez-Fontán M, Rosales M, Rodríguez-Carmona A, Falcón TG, Valdés F. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 2002;39:337- 341. 17. Wise R, Johnson J. Mupirocin resistance. Lancet 1991;338 (8766):578. 18. Lee HJ, Suh JT, Kim YS, Lenz W, Bierbaum G, Schaal KP. Typing and antimicrobial susceptibilities of methicillin resis- tant Staphylococcus aureus (MRSA) strains isolated in a hospital in Korea. J Korean Med Sci 2001;16:381-385. 19. Redhead RJ, Lamb YJ, Rowsell RB. The efficacy of calcium mupirocin in the eradication of nasal Staphylococcus aureus carriage. Br J Clin Pract 1991;45:252-254. 20. Janssen DA, Zarins LT, Schaberg DR, Bradley SF, Terpenning MS, Kauffman CA. Detection and characterization of mupiro- cin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1993;37:2003-2006. 21. Chaves F, García-Martínez J, de Miguel S, Otero JR. Mole- cular characterization of resistance to mupirocin in methicillin- susceptible and -resistant isolates of Staphylococcus aureus from nasal samples. J Clin Microbiol 2004;42:822-824. 22. Thomas DG, Wilson JM, Day MJ, Russell AD. Mupirocin resistance in staphylococci: development and transfer of isoleucyl-tRNA synthetase-mediated resistance in vitro. J Appl Microbiol 1999;86:715-722. 23. Bastos MC, Mondino PJ, Azevedo ML, Santos KR, Giambiagi- deMarval M. Molecular characterization and transfer among Staphylococcus strains of a plasmid conferring high-level resistance to mupirocin. Eur J Clin Microbiol Infect Dis 1999;18:393-398. 24. Kim SM, Lee DC, Park SD, Kim BS, Kim JK, Choi MR, et al. Genotype, coagulase type and antimicrobial susceptibility of methicillin-resistant staphylococcus aureus isolated from dermatology patients and Healthy Individuals in Korea. J Bacteriol Virol 2009;39:307-316. 25. Maple PA, Hamilton-Miller JM, Brumfitt W. Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus. J Antimi- crob Chemother 1992;29:661-668. 26. Riley TV, Carson CF, Bowman RA, Mulgrave L, Golledge CL, Pearman JW, et al. Mupirocin-resistant methicillin-resis- tant Staphylococcus aureus in Western Australia. Med J Aust 1994;161:397-398. 38 Ann Dermatol